Jump Financial, LLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1831577 Chicago, IL

Position in XENE

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$15,737,662

+$6,679,288 QoQ

Shares Held

260,730

+67.4% QoQ

Ownership

0.269%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#65

of 313 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. XENE ranks #3 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc. This page	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,737,662	260,730	+67.4%	Shares	Defined	2026-08-13
2026-03-31	$9,058,374	155,776	+402.7%	Shares	Defined	2026-05-14
2025-12-31	$1,388,837	30,987	+376.7%	Shares	Defined	2026-02-17
2025-09-30	$260,975	6,500	-61.7%	Shares	Defined	2025-11-13
2025-06-30	$531,818	16,991	-62.2%	Shares	Defined	2025-08-13
2024-09-30	$1,771,650	45,000	-6.6%	Shares	Defined	2024-11-14
2024-06-30	$1,877,992	48,166	+4.5%	Shares	Defined	2024-11-14
2024-03-31	$1,983,700	46,079	+92.0%	Shares	Sole	2024-05-13
2023-12-31	$1,105,440	24,000	+210.7%	Shares	Sole	2024-10-21
2022-12-31	$304,596	7,725	-85.5%	Shares	Sole	2023-02-14
2022-09-30	$1,924,130	53,300	+77.1%	Shares	Sole	2022-11-07
2022-03-31	$920,187	30,101	-3.8%	Shares	Sole	2022-05-12
2021-12-31	$977,812	31,300	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.